Accustem Sciences annual stock-based compensation
2021
2022
2023
2024
2025
Accustem Sciences Stock-Based Compensation Growth & History (ACUT)
Accustem Sciences's stock-based compensation was $88,695 for fiscal 2025.
View full Accustem Sciences company overviewAccustem Sciences annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $88,695 | $18,977 | +27.22% |
| 2024 | 2024-12-31 | $69,718 | −$8,916 | −11.34% |
| 2023 | 2023-12-31 | $78,634 | −$55,255 | −41.27% |
| 2022 | 2022-12-31 | $133,889 | $112,629 | +529.77% |
| 2021 | 2021-12-31 | $21,260 | — | — |
Accustem Sciences quarterly stock-based compensation
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $7,303 | −$15,938 | −68.58% |
| Q1 2026 | 2026-03-31 | $15,161 | −$2,946 | −16.27% |
| Q4 2025 | 2025-12-31 | $23,673 | $4,902 | +26.11% |
| Q3 2025 | 2025-09-30 | $23,674 | $4,828 | +25.62% |
| Q2 2025 | 2025-06-30 | $23,241 | $9,308 | +66.81% |
| Q1 2025 | 2025-03-31 | $18,107 | −$61 | −0.34% |
| Q4 2024 | 2024-12-31 | $18,771 | −$1,128 | −5.67% |
| Q3 2024 | 2024-09-30 | $18,846 | −$1,054 | −5.30% |
| Q2 2024 | 2024-06-30 | $13,933 | $1,307 | +10.35% |
| Q1 2024 | 2024-03-31 | $18,168 | −$8,041 | −30.68% |
| Q4 2023 | 2023-12-31 | $19,899 | −$21,361 | −51.77% |
| Q3 2023 | 2023-09-30 | $19,900 | −$18,101 | −47.63% |
| Q2 2023 | 2023-06-30 | $12,626 | −$24,962 | −66.41% |
| Q1 2023 | 2023-03-31 | $26,209 | $9,169 | +53.81% |
| Q4 2022 | 2022-12-31 | $41,260 | — | — |
| Q3 2022 | 2022-09-30 | $38,001 | — | — |
| Q2 2022 | 2022-06-30 | $37,588 | — | — |
| Q1 2022 | 2022-03-31 | $17,040 | — | — |
Accustem Sciences stock-based compensation trends
Between the periods ended 2021-12-31 and 2025-12-31, Accustem Sciences's stock-based compensation increased from $21,260 to $88,695, a change of $67,435. The latest reported quarter, Q2 2026, shows $7,303.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Accustem Sciences source filings ↗